CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-01 | Leonard Frank X President, CNS Cancers US | Grant or award | +6,830 | 50,456 | ||
| 2022-11-01 | Leonard Frank X President, CNS Cancers US | Grant or award · Options to Buy Ordinary Shares | +11,609 | $73.20 | $850K | 11,609 |
| 2022-10-13 | Leonard Frank X President, CNS Cancers US | Sale | −6,754 | $76.01 | $513K | 43,626 |
| 2022-10-06 | Leonard Frank X President, CNS Cancers US | Sale | −6,754 | $84.37 | $570K | 50,380 |
| 2022-09-29 | Leonard Frank X President, CNS Cancers US | Sale | −6,754 | $77.35 | $522K | 57,134 |
| 2022-09-22 | Leonard Frank X President, CNS Cancers US | Sale | −6,754 | $77.00 | $520K | 63,888 |
| 2022-09-15 | Leonard Frank X Chief Development Officer | Exercise or conversion | +5,517 | $7.15 | $39K | 82,913 |
| 2022-09-15 | Leonard Frank X Chief Development Officer | Sale | −6,754 | $87.31 | $590K | 76,159 |
| 2022-09-15 | Leonard Frank X Chief Development Officer | Sale | −5,517 | $90.00 | $497K | 70,642 |
| 2022-09-15 | Leonard Frank X Chief Development Officer | Exercise or conversion · Options to Buy Ordinary Shares | −5,517 | 5,517 | ||
| 2022-09-09 | Leonard Frank X Chief Development Officer | Sale | −1,863 | $88.00 | $164K | 84,150 |
| 2022-09-08 | Leonard Frank X Chief Development Officer | Sale | −6,754 | $81.48 | $550K | 77,396 |
| 2022-09-06 | Leonard Frank X Chief Development Officer | Sale | −1,384 | $78.57 | $109K | 86,013 |
| 2022-09-02 | Burke William Patrick Chief Human Resources Officer | Sale | −718 | $79.04 | $57K | 55,486 |
| 2022-09-02 | Cordova Ashley Chief Financial Officer | Sale | −885 | $79.04 | $70K | 72,376 |
| 2022-09-02 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Sale | −296 | $79.04 | $23K | 165,024 |
| 2022-09-02 | Shah Pritesh Chief Commercial Officer | Sale | −269 | $79.04 | $21K | 83,230 |
| 2022-09-02 | Leonard Frank X Chief Development Officer | Sale | −584 | $79.04 | $46K | 87,397 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −1,047 | $75.94 | $80K | 101,146 |
| 2022-09-01 | Leonard Frank X Chief Development Officer | Sale | −1,914 | $77.00 | $147K | 99,232 |
Page 19 of 20 · 399 trades